HomeCNTX • NASDAQ
Follow
Context Therapeutics Inc
Previous close
$1.47
Day range
$1.37 - $1.52
Year range
$0.47 - $1.69
Market cap
22.19M USD
Avg Volume
86.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 6.93M | 78.58% |
Net income | -6.77M | -90.34% |
Net profit margin | — | — |
Earnings per share | -0.42 | -90.91% |
EBITDA | -6.93M | -78.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.45M | -59.29% |
Total assets | 16.06M | -57.69% |
Total liabilities | 4.19M | 30.68% |
Total equity | 11.87M | — |
Shares outstanding | 15.97M | — |
Price to book | 1.99 | — |
Return on assets | -88.77% | — |
Return on capital | -114.58% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.77M | -90.34% |
Cash from operations | -7.23M | -83.91% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -7.23M | -83.91% |
Free cash flow | -4.79M | -70.81% |
About
Founded
2015
Headquarters
Website
Employees
5